Investor
MWG Caph Ltd
CIK 0002111120 · filed 2026-02-17 · SEC filing
13F book
$72.4M
Positions
3
Largest name
48.5%
Beam Therapeutics Inc. · BEAM
Est. mark
—
Need a prior quarter to estimate
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Beam Therapeutics Inc. | BEAM | 1.27M | $35.1M | 48.5% | — | Held |
| Lyell Immunopharma, Inc. | LYEL | 1.01M | $31M | 42.9% | — | Held |
| Prime Medicine, Inc. | PRME | 1.79M | $6.22M | 8.6% | — | Held |
Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.